NDLI: Placenta-derived gp96 as a multivalent prophylactic cancer vaccine

Content Provider	PubMed Central
Author	Zhao, Bao Wang, Yanzhong Wu, Bo Liu, Shan Wu, Erjie Fan, Hongxia Gui, Mingming Chen, Lizhao Li, Changfei Ying, Ju Zhang, Wei Meng, Songdong
Copyright Year	2013
Abstract	A major challenge for designing prophylactic cancer vaccines is to define immunogenic and safe cancer antigens. Given the striking similarity of antigen expression patterns between cancer and embryonic tissues, we defined a prototype strategy of using placenta-derived heat shock protein gp96, which induces prophylactic anti-tumor T cell responses. Immunization with placental gp96 provided partial protection and long-term (at least 3 months) anti-tumor immunity against growth of transplantable melanoma or breast tumors in mice, elicited total protection against 7, 12-dimethylbenz(a)-anthracene (DMBA)-induced mammary tumors in rats, and significantly reduced the occurrence and growth of autochthonous breast tumors in HER2 transgenic mice. Placental gp96 activated HER2- and MUC1-specific T cell responses through binding to tumor-associated antigens. Our results reveal the novel immunogenicity of placental gp96 and its potential use as a multivalent cancer vaccine.
Related Links	http://dx.doi.org/10.1038/srep01947
Starting Page	1947
File Format	PDF
ISSN	20452322
e-ISSN	20452322
Journal	Scientific Reports
Volume Number	3
Language	English
Publisher	Nature Publishing Group
Publisher Date	2013-06-01
Access Restriction	Open
Rights Holder	Nature Publishing Group
Subject Keyword	Science and technology Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Multidisciplinary

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Placenta-derived gp96 as a multivalent prophylactic cancer vaccine

Embryonic-like stem cells derived from postpartum placenta delivered after spotaneous labor emerging as universal prophylactic cancer vaccine

Embryonic-Like Stem Cells Derived from Postpartum Placenta Delivered After Spotaneous Labor Emerging as Universal Prophylactic Cancer Vaccine

Gp96 rich lysate as a vaccine candidate against infection with Salmonella typhimurium

A prophylactic vaccine for breast cancer? Why not?

Co-administration of GP96 and Her2/neu DNA vaccine in a Her2 breast cancer model

Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer

Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk

Human Vaccine as a Prophylactic of Smallpox: Its Advantages and Disadvantages

Placenta-derived gp96 as a multivalent prophylactic cancer vaccine

Similar Documents

Placenta-derived gp96 as a multivalent prophylactic cancer vaccine

Embryonic-like stem cells derived from postpartum placenta delivered after spotaneous labor emerging as universal prophylactic cancer vaccine

Embryonic-Like Stem Cells Derived from Postpartum Placenta Delivered After Spotaneous Labor Emerging as Universal Prophylactic Cancer Vaccine

Gp96 rich lysate as a vaccine candidate against infection with Salmonella typhimurium

A prophylactic vaccine for breast cancer? Why not?

Co-administration of GP96 and Her2/neu DNA vaccine in a Her2 breast cancer model

Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer

Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk

Human Vaccine as a Prophylactic of Smallpox: Its Advantages and Disadvantages

Placenta-derived gp96 as a multivalent prophylactic cancer vaccine